BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35772127)

  • 1. ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis.
    Giustozzi M; Proietti G; Becattini C; Roila F; Agnelli G; Mandalà M
    Blood Adv; 2022 Aug; 6(16):4873-4883. PubMed ID: 35772127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review.
    Iyengar V; Agrawal S; Chiasakul T; Tehranchi K; Mcnichol M; Carney BJ; Leader A; Zwicker JI; Patell R
    J Thromb Haemost; 2024 Feb; 22(2):423-429. PubMed ID: 37866517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors.
    Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
    J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: A meta-analysis.
    Yang J; He Z; Li M; Hong T; Ouyang T
    J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107243. PubMed ID: 37413715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases.
    Leader A; Hamulyák EN; Carney BJ; Avrahami M; Knip JJ; Rozenblatt S; Beenen LFM; Yust-Katz S; Icht O; Coppens M; Raanani P; Middeldorp S; Büller HR; Zwicker JI; Spectre G
    Blood Adv; 2020 Dec; 4(24):6291-6297. PubMed ID: 33351124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study.
    Reed-Guy L; Desai AS; Phillips RE; Croteau D; Albright K; O'Neill M; Brem S; O'Rourke DM; Amankulor NM; Bagley SJ
    Neuro Oncol; 2022 Dec; 24(12):2172-2179. PubMed ID: 35551405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies.
    Swartz AW; Drappatz J
    Oncologist; 2021 May; 26(5):427-432. PubMed ID: 33523555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.
    Wu T; Lv C; Wu L; Chen W; Lv M; Jiang S; Zhang J
    J Neurol; 2022 Feb; 269(2):664-675. PubMed ID: 33594452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of intracranial hemorrhage in glioma patients receiving anticoagulant treatment for venous thromboembolism: a bayesian network meta-analysis.
    Huo H; Shen S; Yang Y; Zhang H; Wu S; Bi T; Li Y
    J Thromb Thrombolysis; 2023 Aug; 56(2):333-341. PubMed ID: 37341895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.
    Rojas-Hernandez CM; Oo TH; García-Perdomo HA
    J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant prescribing patterns in patients with primary central nervous system malignancies and secondary metastases.
    Abdelmessih E; Ahuja T; Wo S; Sango A; Papadopoulos J; Green D; Xiang E
    J Thromb Thrombolysis; 2024 Mar; 57(3):418-427. PubMed ID: 38281232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage: A Systematic Review and Meta-analysis.
    Chaudhary R; Singh A; Chaudhary R; Bashline M; Houghton DE; Rabinstein A; Adamski J; Arndt R; Ou NN; Rudis MI; Brown CS; Wieruszewski ED; Wanek M; Brinkman NJ; Linderbaum JA; Sorenson MA; Atkinson JL; Thompson KM; Aiyer AN; McBane RD
    JAMA Netw Open; 2022 Nov; 5(11):e2240145. PubMed ID: 36331504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis.
    Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R
    Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal oral anticoagulant-related intracranial hemorrhage: a systematic review and meta-analysis.
    Katsanos AH; Schellinger PD; Köhrmann M; Filippatou A; Gurol ME; Caso V; Paciaroni M; Perren F; Alexandrov AV; Tsivgoulis G
    Eur J Neurol; 2018 Oct; 25(10):1299-1302. PubMed ID: 29953696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis.
    Zhou Z; Yu J; Carcel C; Delcourt C; Shan J; Lindley RI; Neal B; Anderson CS; Hackett ML
    BMJ Open; 2018 May; 8(5):e019672. PubMed ID: 29764874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis.
    Dong S; Zhang Y; Li Y; Li Y; Miao Y; Zhao R; Zhai S
    Ann Pharmacother; 2021 Apr; 55(4):430-439. PubMed ID: 32938202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysis.
    Dong Y; Wang Y; Ma RL; Liu M; Gao JZ; Su WY; Yan L; Sun JJ
    J Thromb Thrombolysis; 2019 Oct; 48(3):400-412. PubMed ID: 31062143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Intracranial Hemorrhage Caused by Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation (from a Network Meta-Analysis of Randomized Controlled Trials).
    Lv M; Wu T; Jiang S; Chen W; Zhang J
    Am J Cardiol; 2022 Jan; 162():92-99. PubMed ID: 34756593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.
    Zwicker JI; Karp Leaf R; Carrier M
    J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.